N. Sadanaga et al., Local secretion of IFN-gamma induces an antitumor response: Comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells, J IMMUNOTH, 22(4), 1999, pp. 315-323
Previously we described that the adoptive transfer of tumor-infiltrating ly
mphocytes (TIL) + interleukin-2 (IL-2) leads to eradication of established
methyl cholanthrene (MCA)-105 fibrosarcoma pulmonary metastases in a congen
ic murine model. The in vivo efficacy of TIL was associated with their abil
ity to secrets interferon-gamma (IFN-gamma), and to a lesser extent granulo
cyte-macrophage colony-stimulating factor. The local secretion of these cyt
okines resulted in recruitment of naive host immune cells to the tumor and
eventually in a successful host antitumor immune response. In the present s
tudy, to further evaluate the role of IFN-gamma in the induction of a host
antitumor immune response, we compared the treatment efficacy of adoptively
transferred T cells and IFN-gamma gene transfected tumor cells (MCA-105/IF
N-gamma) as delivery systems of IFN-gamma. Treatment with TIL-IL-2 or irrad
iated MCA-105/IFN-gamma induced a similar reduction in pulmonary metastases
of MCA-105 tumor. In contrast, irradiated wild-type MCA-105 or TIL from IF
N-gamma gene knockout mice did not cause tumor eradication. MCA-105 tumor-b
earing mice treated with MCA-205/IFN-gamma showed a partial reduction in th
e number of pulmonary metastases. Histologically, lungs of successfully tre
ated mice showed that initially activated macrophages expressing inducible
nitric oxide synthase (iNOS) and dendritic cells infiltrated the tumor bed.
Subsequently, CD4(+) and CD8(+) T cells infiltrated tumors. The therapeuti
c efficacy of IFN-gamma transfected tumor cells was eliminated when either
CD4(+) T cells or CD8(+) T cells were depleted. These results suggest that
local secretion of IFN-gamma induces a tumor-specific host antitumor immune
response mediated through activated macrophages, dendritic cells, and tumo
r-specific T cells. This may be a common component of successful immunother
apy.